Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study
QUESTIONS UNDER STUDY: The differentiation between infectious and noninfectious pulmonary complications is challenging. Rapid, accurate microbiological results may allow appropriate antibiotic therapy, withholding or adapting antibiotics, and thus reducing costs and risks of empirical antibiotic t...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2015-09-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/2081 |
_version_ | 1811289175354245120 |
---|---|
author | Kathleen Jahn Marko Kuisma Minna Mäki Peter Grendelmeier Hans H. Hirsch Michael Tamm Eleni Papakonstantinou Daiana Stolz |
author_facet | Kathleen Jahn Marko Kuisma Minna Mäki Peter Grendelmeier Hans H. Hirsch Michael Tamm Eleni Papakonstantinou Daiana Stolz |
author_sort | Kathleen Jahn |
collection | DOAJ |
description |
QUESTIONS UNDER STUDY: The differentiation between infectious and noninfectious pulmonary complications is challenging. Rapid, accurate microbiological results may allow appropriate antibiotic therapy, withholding or adapting antibiotics, and thus reducing costs and risks of empirical antibiotic therapy. The objective of this proof-of-concept pilot study was to investigate the diagnostic yield of a new polymerase chain-reaction (PCR) and microarray-based rapid molecular diagnostic assay and compare the results to conventional microbiology cultures and clinical judgment.
METHODS: Bronchoalveolar lavage specimens were obtained from 35 patients undergoing bronchoscopy for diagnostic reasons. Cases (n = 22) consisted of patients with suspicion of pulmonary bacterial infection. Controls (n = 13) were identified among patients undergoing bronchoscopy for indications other than suspicion of infection.
RESULTS: Demographics were similar in cases and controls. The majority (73%) of patients with pulmonary infection were on empirical antibiotic therapy. Among the 22 cases, bacteria were identified by means of PCR in 77% (n = 17) as compared with 41% (n = 9) by culture (p = 0.030). In contrast, controls yielded a PCR positive result in 45% (n = 7), as compared with no positive cultures (p = 0.005). Compared with culture results, PCR had a sensitivity of 87.5% (95% confidence interval [CI] 47.4–97.9) and specificity of 28.6% (95% CI 8.6–58.1) to diagnose bacterial infection. Compared with clinical judgment, corresponding figures were 77.3% (95% CI 54.5–91.1) and 46.2% (95% CI 19.3–74.8), respectively.
CONCLUSION: The PCR- and microarray-based rapid molecular diagnostic assay offers an alternative to conventional cultures for detection of potentially pathogenic bacteria in bronchoalveolar lavage of patients with pneumonia. However, the clinical relevance is unclear as it may also detect colonisers in patients without a corresponding infection.
|
first_indexed | 2024-04-13T03:50:14Z |
format | Article |
id | doaj.art-91dcba3d40f34101a744ae55075e43fb |
institution | Directory Open Access Journal |
issn | 1424-3997 |
language | English |
last_indexed | 2024-04-13T03:50:14Z |
publishDate | 2015-09-01 |
publisher | SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
record_format | Article |
series | Swiss Medical Weekly |
spelling | doaj.art-91dcba3d40f34101a744ae55075e43fb2022-12-22T03:03:51ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972015-09-01145394010.4414/smw.2015.14193Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot studyKathleen JahnMarko KuismaMinna MäkiPeter GrendelmeierHans H. HirschMichael TammEleni PapakonstantinouDaiana Stolz QUESTIONS UNDER STUDY: The differentiation between infectious and noninfectious pulmonary complications is challenging. Rapid, accurate microbiological results may allow appropriate antibiotic therapy, withholding or adapting antibiotics, and thus reducing costs and risks of empirical antibiotic therapy. The objective of this proof-of-concept pilot study was to investigate the diagnostic yield of a new polymerase chain-reaction (PCR) and microarray-based rapid molecular diagnostic assay and compare the results to conventional microbiology cultures and clinical judgment. METHODS: Bronchoalveolar lavage specimens were obtained from 35 patients undergoing bronchoscopy for diagnostic reasons. Cases (n = 22) consisted of patients with suspicion of pulmonary bacterial infection. Controls (n = 13) were identified among patients undergoing bronchoscopy for indications other than suspicion of infection. RESULTS: Demographics were similar in cases and controls. The majority (73%) of patients with pulmonary infection were on empirical antibiotic therapy. Among the 22 cases, bacteria were identified by means of PCR in 77% (n = 17) as compared with 41% (n = 9) by culture (p = 0.030). In contrast, controls yielded a PCR positive result in 45% (n = 7), as compared with no positive cultures (p = 0.005). Compared with culture results, PCR had a sensitivity of 87.5% (95% confidence interval [CI] 47.4–97.9) and specificity of 28.6% (95% CI 8.6–58.1) to diagnose bacterial infection. Compared with clinical judgment, corresponding figures were 77.3% (95% CI 54.5–91.1) and 46.2% (95% CI 19.3–74.8), respectively. CONCLUSION: The PCR- and microarray-based rapid molecular diagnostic assay offers an alternative to conventional cultures for detection of potentially pathogenic bacteria in bronchoalveolar lavage of patients with pneumonia. However, the clinical relevance is unclear as it may also detect colonisers in patients without a corresponding infection. https://www.smw.ch/index.php/smw/article/view/2081molecular diagnosticsbacterial infectionsbronchoalveolar lavagePCRclinical judgment |
spellingShingle | Kathleen Jahn Marko Kuisma Minna Mäki Peter Grendelmeier Hans H. Hirsch Michael Tamm Eleni Papakonstantinou Daiana Stolz Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study Swiss Medical Weekly molecular diagnostics bacterial infections bronchoalveolar lavage PCR clinical judgment |
title | Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study |
title_full | Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study |
title_fullStr | Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study |
title_full_unstemmed | Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study |
title_short | Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study |
title_sort | molecular diagnostics for bacterial infections in bronchoalveolar lavage a case control pilot study |
topic | molecular diagnostics bacterial infections bronchoalveolar lavage PCR clinical judgment |
url | https://www.smw.ch/index.php/smw/article/view/2081 |
work_keys_str_mv | AT kathleenjahn moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy AT markokuisma moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy AT minnamaki moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy AT petergrendelmeier moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy AT hanshhirsch moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy AT michaeltamm moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy AT elenipapakonstantinou moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy AT daianastolz moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy |